Plain-English translation of NCT06365021 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bipolar Disorder research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether Acceptance and Commitment Therapy (ACT)—a type of talk therapy—can help reduce depression symptoms in people with bipolar disorder. Some participants will attend 12 weekly therapy sessions over 3 months, while others will receive standard care plus brief education sessions. The researchers want to see if this treatment helps not just with depression, but also with sleep, daily functioning, and overall quality of life.
While this talk therapy has shown promise for other mental health conditions, there is very limited research on whether it works specifically for bipolar disorder depression. This trial aims to fill that gap and give doctors better tools to help people manage the depressive side of bipolar disorder.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to one of two groups. One group will attend 12 weekly group therapy sessions (each about 2 hours long) over 3 months, plus continue taking their regular medications. The other group will have their usual medications and attend 3 shorter education sessions. Both groups will complete short surveys and check-ins at the start, end, and at 6, 9, and 12 months to track how you're doing.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Brazil